Prospective study into COVID-19-like symptoms in patients with and without immune-mediated inflammatory diseases or immunomodulating drugs

Ann Rheum Dis. 2021 Oct;80(10):1364-1365. doi: 10.1136/annrheumdis-2021-219958. Epub 2021 Apr 13.
No abstract available

Keywords: Covid-19; antirheumatic agents; autoimmune diseases.

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • COVID-19 / epidemiology*
  • COVID-19 / immunology*
  • Humans
  • Immunocompromised Host / immunology*
  • Incidence
  • Prospective Studies
  • SARS-CoV-2

Substances

  • Antirheumatic Agents